Marketing-authorisation holder · Spain
Bayer Hispania S.L.
116 medicines in 1 country, as authorisation holder, manufacturer and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
116 medicines in 1 country, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 116
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTIRA 400 MG/ 250 ML SOLUCION PARA PERFUSION0,436 g · Solución para perfusión | Moxifloxacin | Spain | Marketed | 2018 |
| ACTROMADOL 660 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA660 mg · Comprimido de liberación modificada | Naproxen | Spain | Marketed | 2018 |
| ACTRON COMPUESTO 267 MG/133 MG/40 MG COMPRIMIDOS EFERVESCENTES133 mg + 40 mg + 267 mg · Comprimido efervescente | Paracetamol, Caffeine, Acetylsalicylic acid | Spain | Marketed | 1968 |
| ADALAT OROS 30 mg, COMPRIMIDOS DE LIBERACION PROLONGADA30 mg · Comprimido de liberación prolongada | Nifedipine | Spain | Marketed | 1992 |
| ADIRO 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG100 mg · Comprimido gastrorresistente | Acetylsalicylic acid | Spain | Marketed | 1999 |
| ALKA-SELTZER 2,1 g COMPRIMIDOS EFERVESCENTES2.081,8 mg · Comprimido efervescente | Bicarbonate | Spain | Marketed | 1965 |
| ANGELIQ 1 mg/2 mg COMPRIMIDOS RECUBIERTOS CON PELICULA2 mg + 1.000 mg · Comprimido recubierto con película | Drospirenone, Estradiol | Spain | Marketed | 2003 |
| ASPIRINA 500 mg COMPRIMIDOS500 mg · Comprimido | Acetylsalicylic acid | Spain | Marketed | 1922 |
| ASPIRINA 500 mg COMPRIMIDOS EFERVESCENTES500 mg · Comprimido efervescente | Acetylsalicylic acid | Spain | Marketed | 2005 |
| ASPIRINA 500 mg GRANULADO500 mg · Granulado | Acetylsalicylic acid | Spain | Marketed | 2006 |
| ASPIRINA C 400 mg/240 mg COMPRIMIDOS EFERVESCENTES400 mg + 240 mg · Comprimido efervescente | Acetylsalicylic acid, Ascorbic acid | Spain | Marketed | 1973 |
| ASPIRINA COMPLEX GRANULADO EFERVESCENTE500 mg + 2 mg + 15,58 mg · Granulado efervescente | Acetylsalicylic acid, Chlorpheniramine, Fenilefrina bitartrato | Spain | Marketed | 1998 |
| ASPIRINA PLUS 500 mg/ 50 mg COMPRIMIDOS500 mg + 50 mg · Comprimido | Acetylsalicylic acid, Caffeine | Spain | Marketed | 1949 |
| BECOZYME C FORTE COMPRIMIDOS RECUBIERTOS15 mg + 50 mg + 10 mg + 25 mg + 0,15 mg + 10 µg + 200 mg + 15 mg · Comprimido recubierto | Vitamin b2, Nicotinamide, Vitamin b6, D-pantothenic acid, Biotin, Vitamin b12, Ascorbic acid, Vitamin b1 | Spain | Marketed | 1965 |
| BENEXOL B1-B6-B12 COMPRIMIDOS RECUBIERTOS CON PELICULA250 mg + 250 mg + 1 mg · Comprimido recubierto con película | Vitamin b1, Vitamin b6, Vitamin b12 | Spain | Marketed | 1964 |
| BEPANMED 500 mg/2 ml, SOLUCION INYECTABLE500 mg · Solución inyectable | D-pantenol | Spain | Marketed | 1952 |
| CAFIASPIRINA 500 mg/50 mg COMPRIMIDOS50 mg + 500 mg · Comprimido | Caffeine, Acetylsalicylic acid | Spain | Marketed | 1927 |
| CANESPIE BIFONAZOL 10 mg/g CREMA10 mg · Crema | Bifonazole | Spain | Marketed | 2011 |
| CANESPIE BIFONAZOL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA1 g · Solución cutánea | Bifonazole | Spain | Marketed | 1987 |
| CANESPIE CLOTRIMAZOL 10 mg/g CREMA1 g · Crema | Clotrimazole | Spain | Marketed | 2008 |
| CANESTEN 10 mg/g CREMA1,00 g · Crema | Clotrimazole | Spain | Marketed | 1975 |
| CANESTEN 10 mg/g POLVO CUTANEO1,00 g · Polvo cutáneo | Clotrimazole | Spain | Marketed | 1985 |
| CANESTEN 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA1 g · Solución para pulverización cutánea | Clotrimazole | Spain | Marketed | 1975 |
| CLARITYNE 10 mg COMPRIMIDOS10 mg · Comprimido | Loratadine | Spain | Marketed | 1990 |
| CLARITYNE PLUS 10mg/240mg COMPRIMIDOS DE LIBERACION PROLONGADA240 mg + 10 mg · Comprimido de liberación prolongada | Pseudoephedrine, Loratadine | Spain | Marketed | 2000 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 116 | 85 | 31 | CompaniesAll medicines |
Also in the registers of Brazil
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.